Wednesday, July 9, 2025
HomeNews

News

Hansa Biopharma Announces $70 Million Non-dilutive Product Finance Transaction With Novaquest

Hansa Biopharma AB, a pioneer in enzyme technology for rare immunological conditions, announces that the Company has entered into an agreement with U.S.-based NovaQuest...

RegeneRx Partner Signs LOI with Global Ophthalmology CRO for Two Phase 3 Clinical Trials in Neurotrophic Keratitis

RegeneRx Biopharmaceuticals, Inc., a clinical-stage drug development company focused on tissue protection, repair, and regeneration, is reporting today that its U.S. joint venture (JV)...

Medicare Extends Coverage of Natera’s Signatera MRD Test to Muscle Invasive Bladder Cancer

Natera, Inc., a global leader in cell-free DNA testing, announced that it has received written confirmation from the CMS Molecular Diagnostics Services Program (MolDX)...

Vertical Aerospace and Babcock International Partner to Explore New Variants for the VX4

Vertical Aerospace, a global aerospace and technology company that is pioneering zero emissions aviation, announces a partnership with Babcock International, the aerospace, defence and...

Retia Medical Raises $15 Million to Accelerate Commercialization of the Argos Hemodynamic Monitor

Retia Medical, an innovator in advanced hemodynamic monitoring, announced that it has secured $15 million in Series B funding. The financing round was led...
0FansLike
0FollowersFollow
spot_img

Hot Topics